Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.
TipRanks on MSN
Boston Scientific’s global pulsed field ablation trial targets persistent atrial fibrillation growth
Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study OverviewThis global Boston Scientific trial, officially titled ...
The Volt pulsed-field ablation (PFA) system (Abbott) has been approved by the US Food and Drug Administration for the treatment of patients with atrial fibrillation (AF), according to a Monday ...
US FDA approves Abbott's Volt PFA System to treat patients with atrial fibrillation: Abbott Park, Illinois Wednesday, December 24, 2025, 12:00 Hrs [IST] Abbott, is a global health ...
Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.
Seth Rollins has explained that he fully supported Cody Rhodes winning their Hell In A Cell match in 2022, even after ...
Boston Scientific Corporation is rated a Hold with double-digit revenue growth and margin expansion. Learn more about BSX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback